Enanta Pharmaceuticals, Inc. (ENTA) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$2,370
Total Return
-76.30%
CAGR
-25.02%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.08% |
| Median | -1.96% |
| Best | +74.45% |
| Worst | -43.96% |
| % of Windows Positive | 46.3% |
1-Year (252 Trading Days)
| Average | -16.01% |
| Median | -38.54% |
| Best | +243.43% |
| Worst | -82.10% |
| % of Windows Positive | 23.8% |
3-Year (756 Trading Days)
| Average | -78.90% |
| Median | -80.88% |
| Best | -43.87% |
| Worst | -94.23% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -95.62% |
| Average Drawdown | -67.06% |
| Drawdown Duration | 1145 Trading Days (Unrecovered) |
| Sortino Ratio | -0.12 |
| Calmar Ratio | -0.26 |
| CVaR (5%) | -8.43% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -28.73% (-55.21% ann.) | $2872.55 | $0.00 | $0.00 | $0.00 |
| 2025 | +174.26% | +$17426.13 | $0.00 | $0.00 | $0.00 |
| 2024 | -38.89% | $3889.49 | $0.00 | $0.00 | $0.00 |
| 2023 | -79.77% | $7977.21 | $0.00 | $0.00 | $0.00 |
| 2022 | -37.79% | $3779.09 | $0.00 | $0.00 | $0.00 |
| 2021 | +77.62% | +$7762.47 | $0.00 | $0.00 | $0.00 |
| 2020 | -31.85% | $3185.50 | $0.00 | $0.00 | $0.00 |
| 2019 | -12.78% | $1277.71 | $0.00 | $0.00 | $0.00 |
| 2018 | +20.71% | +$2070.55 | $0.00 | $0.00 | $0.00 |
| 2017 | +75.16% | +$7516.41 | $0.00 | $0.00 | $0.00 |
| 2016 | +1.45% | +$145.37 | $0.00 | $0.00 | $0.00 |
| 2015 | -35.06% | $3506.39 | $0.00 | $0.00 | $0.00 |
| 2014 | +86.40% | +$8640.03 | $0.00 | $0.00 | $0.00 |
| 2013 partial | +58.79% (+80.87% ann.) | +$5878.93 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | March 21, 2013 – February 19, 2020 | +210.54% | +17.80% | +$21053.55 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -13.86% | -81.78% | $1385.97 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -6.36% | -10.04% | $636.50 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +93.82% | +87.36% | +$9382.47 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -53.06% | -55.20% | $5305.85 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -74.11% | -51.76% | $7411.11 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -1.32% | -0.77% | $131.69 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.